Nanoviricides (NNVC) Other financing activities (2013 - 2021)
Nanoviricides' (NNVC) quarterly Other financing activities came in at $37408.0 in Q4 2021, up 191.19% year-over-year from $12846.8 in Q4 2020, and up 191.19% quarter-over-quarter from -$41024.0 in Q4 2020.
Powered by 
Analysis
Nanoviricides (NNVC) Other financing activities (2013 - 2021) Analysis & Trends
Nanoviricides has disclosed Other financing activities across 6 years of filings, most recently posting $37408.0 for Q4 2021.
- In Q4 2021, Other financing activities rose 191.19% year-over-year to $37408.0; the TTM figure through Mar 2022 stood at $37408.0 (down 73.48% YoY), while the FY2020 annual figure was $12190.0, changed N/A from the prior year.
- Other financing activities came in at $37408.0 for Q4 2021 at Nanoviricides, up from -$41024.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $242105.0 in Q3 2019 to a low of -$41024.0 in Q4 2020.
- Average Other financing activities over 3 years is $84116.6, with a median of $41024.0 recorded in 2020.
- Year-over-year, Other financing activities tumbled 129.08% in 2020 and surged 191.19% in 2021.
- Over 3 years, Other financing activities stood at $141070.0 in 2019, then plunged by 129.08% to -$41024.0 in 2020, then surged by 191.19% to $37408.0 in 2021.
- Per Business Quant data, the three most recent Other financing activities figures were $37408.0 in Q4 2021, -$41024.0 in Q4 2020, and $41024.0 in Q3 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Nanoviricides | 22.04 Mn | 18.83 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 37,408.00 |
| Dec 31, 2020 | -41,024.00 |
| Sep 30, 2020 | 41,024.00 |
| Dec 31, 2019 | 141,070.00 |
| Sep 30, 2019 | 242,105.00 |
| Mar 31, 2015 | 2.00 |
| Dec 31, 2014 | 60,998.00 |
| Sep 30, 2014 | 6.68 Mn |
| Jun 30, 2014 | 3.00 |
| Mar 31, 2014 | 18.91 Mn |
| Sep 30, 2013 | 9.69 Mn |